Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from FDA

These Celebrities Admitted To Taking Ozempic, And Some Had Terrible Side Effects

Though the drug only received FDA approval for the treatment of type 2 diabetes, these high-profile individuals have used it for weight loss. Some quit after a few weeks. The post These Celebrities Admitted To Taking Ozempic, And Some Had Terrible Side Effects first appeared on Bored Panda.

US Approves First Drug For Severe Form Of Fatty Liver Disease

US Approves First Drug For Severe Form Of Fatty Liver Disease

The US Food and Drug Administration (FDA) on Thursday approved the first medication for people with a severe type of non-alcoholic fatty liver disease.

International Business Times

Cancer Patients In The Philippines Falling For Alternative 'Cures'

Cancer Patients In The Philippines Falling For Alternative 'Cures'

Filipino single mother Mary Ann Eduarte delayed chemotherapy for her breast cancer for several years and instead took food supplements falsely promoted on social media as cures for the deadly disease.

International Business Times

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Madrigal Stock Soars 11% After FDA Approved The First MASH Treatment

After a bumpy road, Madrigal gained FDA approval for the first-ever MASH treatment, Rezdiffra, and Madrigal stock skyrocketed.

Investors Business Daily

Most US sandwich baggies contain toxic PFAS ‘forever chemicals’, analysis says

Testing commissioned by Mamavation blog found high levels of a marker of PFAS in nine of 11 baggies tested

The Guardian - US

1 AI Growth Stock With 54% Upside Potential

Shares of Recursion Pharmaceuticals offer solid upside potential, given the company's trailblazing approach to drug discovery leveraging AI. Here’s a closer look at the biotech stock that has garnered investments from both AI chipmaker Nvidia and ARKK fund manager Cathie Wood.

Here are the concerns with artificial food dyes, as California weighs a ban in schools

Six artificial food dyes and titanium dioxide would be banned in schools under a proposal in the state legislature. Critics say there isn't enough evidence to prove they're a health risk.

inkl

Read news from The Economist, FT, and more,
with one subscription

A simple blood test can detect colorectal cancer early, study finds

A simple blood test can detect colorectal cancer early, study finds

At a time when colorectal cancer is rising, researchers say a blood test can detect 83% of people with the disease. If the FDA approves it the test would be another screening tool for early detection.

Growing teen THC use could further complicate cannabis policy - Roll Call

Growing teen THC use could further complicate cannabis policy - Roll Call

Adolescents are using an often unregulated, psychoactive derivative of cannabis, according to national data released Wednesday.

Abortion Pill Studies Retracted: Politics or Science?

"Following the science" as the Supreme Court considers the safety and efficacy of medical abortions.

COVID patients can't get Paxlovid

COVID patients can't get Paxlovid

The price is one reason Paxlovid is not reaching those who need it most

Why covid patients who could most benefit from paxlovid still aren’t getting it

During the pandemic, the federal government offered Americans a 5-day course of Paxlovid, the antiviral drug that lessens COVID-19 symptoms. But now that Pfizer is charging for it, confusion over insurance coverage, price, has made patients wary.

The Texas Tribune

Civil servants threaten ministers with legal action over Rwanda bill

Civil servants threaten ministers with legal action over Rwanda bill

Union says Home Office staff could be in breach of international law if they implement deportations

The Guardian - UK

Federal courts seek to stop ‘judge shopping’ with new rule - Roll Call

Federal courts seek to stop ‘judge shopping’ with new rule - Roll Call

The federal judiciary announced a new rule Tuesday on how cases are assigned to judges to discourage so-called “judge shopping” nationwide.

Get all your
news in one place.

100’s of premium titles.
One news app.

There's a new prescription pill for postpartum depression. How will coverage work?

A prescription pill to treat postpartum depression hit the market in December, but most insurers do not yet have a policy on how patients can access it or when they will pay for it.

AirPods Pro could double as hearing aids after this rumored iOS 18 update

Your AirPods Pro might be getting a "major new hearing aid mode" with the iOS 18 release later this year.

iOS 18 could bring ‘Hearing Aid Mode’ to AirPods Pro — what you need to know

A report claims that Apple won't release new AirPods Pro earbuds this year, but that the iOS 18 update could add a hearing aid mode for the earbuds.

Top 3 Biotech Stocks to Anchor Your Portfolio

Amid robust global medicine spending, surging biopharma M&A activity, and technological advancements, the biotech industry is set for significant growth this year and beyond. Given the industry’s bright prospects, top biotech stocks Corcept Therapeutics (CORT), Entrada Therapeutics (TRDA), and Exelixis (EXEL) might be ideal buys now to anchor one’s portfolio.…

Get all your
news in one place.

100’s of premium titles.
One news app.

Apple tipster says AirPods Pro are getting a new hearing aid mode in iOS 18

Why spend thousands of dollars on a hearing aid if your AirPods Pro can do the same job for considerably less cash?

FDA Approves Novo Nordisk's Wegovy For Lowering Heart Risks

FDA approves Novo Nordisk's Wegovy for reducing heart risks in weight management. Novo Nordisk's innovative solution targets weight management and heart risks.

FDA approves Wegovy for lowering heart attack and stroke risk in overweight patients

The popular weight-loss drug can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are overweight or who have obesity, the FDA said.

International Business Times

US FDA Approves Wegovy To Cut Risk Of Heart Problems

The US Food and Drug Administration has given the green light for a popular anti-obesity drug to be used to prevent serious heart conditions for the first time, in a move likely to expand insurance coverage.

Stocks Give Up Early Gains and Close Lower as Chip Stocks Retreat

The S&P 500 Index ($SPX ) (SPY ) Friday closed down -0.65%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.18% and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.53%. Stock indexes on Friday gave up early gains and closed moderately lower. Stocks on...

Wegovy Approved To Reduce Cardiovascular Risk In Overweight Patients

FDA approves Wegovy label change to reduce cardiovascular risk in overweight patients, a significant advancement in obesity treatment with potential implic...

Investors Business Daily

Novo Nordisk Wins FDA Approval For Obesity Drug, Wegovy, To Cut Cardiovascular Risk

Novo Nordisk said Friday its weight-loss drug gained FDA approval to cut the risk of heart attack and strokes. Novo Nordisk stock dipped.

1 … 41 42 43 44

People

Kritika SarmahHer

Matthew Kacsmaryk

William Schaffner

Keith Humphreys

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

the Supreme Court

Harvard University

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

248,388 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play